 |
The 130th Annual Meeting of APHA |
4200.0: Tuesday, November 12, 2002 - Table 3
Abstract #52427
Survival trends of HIV pediatric patients in Mexico: A treatment scheme comparison and the impact of HAART therapy (1986-2001)
Marlene Llópiz-Avilés, BA, MD, MPH1, Miguel Cashat-Cruz, MD, MS2, Juan J. Morales-Aguirre, MD2, and Hortensia Moreno-Macías, MS3. (1) Department of Epidemiology, Harvard School of Public Health, Schiller 310-201, México D.F., Mexico, 52 + (55) + 5684-39-13, mllopiz@hsph.harvard.edu, (2) Department of Epidemiology, Hospital Infantil de México "Federico, Dr. Marquez 162, Colonia Doctores, México D.F., Mexico, (3) Public Health Research Center, Instituto Nacional de Salud Pública, Av. Universidad No. 655, Cuernavaca, Morelos, Mexico
Learning Objectives:
At the conclusion of the session, the participant (learner) in this session will be able to- i.) recognize that survival analysis is a popular data analysis approach for certain kinds of epidemiologic and other data.
- ii.) estimate and interpret survivor and/or hazard function from survival data.
- iii.) assess the relationship of explanatory variables to survival time, in this case different treatment regimens administered in pediatric AIDS cases.
- iv.) interpret Kaplan-Meier (KM) probabilities of survival, given survival time and failure status information on a sample of subjects.
- v.) discuss the impact diverse treatment regimens (mono, double, triple and quadruple therapy) have had on the survival of children with AIDS in Mexico.
Keywords: HIV/AIDS, Children
Related Web page: None
Presenting author's disclosure statement:
I do not have any significant financial interest/arrangement or affiliation with any organization/institution whose products or services are being discussed in this session.
HIV Service Linkage and Delivery, Research and Evaluation
The 130th Annual Meeting of APHA